| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/03/2013 | CN103181959A 中药组合物及其制备方法 Chinese medicine composition and its preparation method |
| 07/03/2013 | CN103181942A Medicine preparation with cruciferous plant extract as active component |
| 07/03/2013 | CN103181936A Ginkgo flavone liposome oral emulsion formula and preparation method thereof |
| 07/03/2013 | CN103181934A Application of herba selaginellae in preparing anti-cancer drugs |
| 07/03/2013 | CN103181933A Preparation method of functional oral preparation rich in erythrothioneine |
| 07/03/2013 | CN103181932A Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system |
| 07/03/2013 | CN103181927A Antineoplastic treatment application of triazole pyrimidine epidermal growth factor receptor antagonist |
| 07/03/2013 | CN103181926A Broad-spectrum antitumor drug and application thereof |
| 07/03/2013 | CN103181918A Application of fatty acid compound in preparation of medicines for preventing and treating liver cancer |
| 07/03/2013 | CN103181913A 一种胡椒碱自乳化软胶囊及其制备方法 One kind of self-emulsifying soft capsules piperine and its preparation method |
| 07/03/2013 | CN103181912A Bexarotene soft capsules and preparation method thereof |
| 07/03/2013 | CN103181900A EPI (epirubicin) SPION (superparamagnetic iron oxide nanoparticle) and preparation method thereof |
| 07/03/2013 | CN103181899A Pepromia pellucida B composition used for inhibiting angiogenesis and preparation method |
| 07/03/2013 | CN103181898A Oxaliplatin liposome and application thereof |
| 07/03/2013 | CN103181897A 吉非替尼脂质体制剂及其制备方法 Gefitinib liposome formulation and preparation method |
| 07/03/2013 | CN103181896A Liposome preparation comprising berbamine medicine, and preparation method thereof |
| 07/03/2013 | CN103181860A Application of suloctidil in preparation of cosmetics or medicine |
| 07/03/2013 | CN103181565A PM2.5-preventing capsule for clearing away lung toxicant and protecting lungs |
| 07/03/2013 | CN102764241B Freeze-dried pharmaceutical composition containing gemcitabine hydrochloride |
| 07/03/2013 | CN102641509B Application of Epstein barr (EB) virus miR-BART7 antisense oligonucleotide in preparing medicine capable of treating nasopharynx cancer |
| 07/03/2013 | CN102579402B Preparation method for vesica of load paclitaxel |
| 07/03/2013 | CN102517283B Special short hairpin ribonucleic acid (shRNA) for reducing human IQGAP1 gene expression and application thereof |
| 07/03/2013 | CN102488661B Method for preparing freeze-dried preparation of combretastatin A4 disodium phosphate |
| 07/03/2013 | CN102451156B Gemcitabine hydrochloride injection preparation and its preparation method |
| 07/03/2013 | CN102295773B Fullerene-terminated poly(benzyl aspartate) and preparation method thereof |
| 07/03/2013 | CN102219811B CA-4 derivatives and preparation method and medicinal application thereof |
| 07/03/2013 | CN102137678B Process for extraction of glucosinolates from broccoli seeds |
| 07/03/2013 | CN102105147B Therapeutic combination comprising an AURORA kinase inhibitor and an antineoplastic agent |
| 07/03/2013 | CN101970418B Pyrazine derivative and its uses as protein kinase inhibitor |
| 07/03/2013 | CN101744770B Ginseng polysaccharide injection and preparation method thereof |
| 07/03/2013 | CN101701024B Ruthenium complex, preparation method thereof and application thereof |
| 07/03/2013 | CN101678007B Gonadotropin-releasing hormone receptor antagonists and its pharmaceutical application |
| 07/03/2013 | CN101665536B Anti-vegf antibodies |
| 07/03/2013 | CN101600718B Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors |
| 07/03/2013 | CN101445555B Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 07/03/2013 | CN101014625B Novel anti-IGF-IR antibodies and uses thereof |
| 07/02/2013 | US8476434 Protein kinase modulators and method of use |
| 07/02/2013 | US8476416 comprises a dinucleotide analog that includes a non-naturally occurring pyrimidine base; for treating autoimmune disorders, such as autoimmune asthma; allergies |
| 07/02/2013 | US8476306 Urokinase inhibitors, production and use thereof |
| 07/02/2013 | US8476285 Purine-core inhibitors of HSP90 and their use in treating cancer |
| 07/02/2013 | US8476282 Benzoxazole kinase inhibitors and methods of use |
| 07/02/2013 | US8476262 Cyanopyrroles |
| 07/02/2013 | US8476260 Antitumor agent |
| 07/02/2013 | US8476254 Methods for treating psychosis associated with interferson-α therapy |
| 07/02/2013 | US8476238 Uses of an immunomodulatory protein (GMI) from Ganoderma microsporum |
| 07/02/2013 | US8476237 Compositions and methods for treating cancer by inhibiting the secretion of microparticles |
| 07/02/2013 | US8475842 Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one |
| 07/02/2013 | US8475834 Method of improving absorption of vitamin E by a pet animal |
| 07/02/2013 | US8475814 Prevention and treatment of breast cancer with 4-hydroxy tamoxifen |
| 07/02/2013 | US8475794 Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases |
| 07/02/2013 | US8475781 Cyclodextrin-based polymers for therapeutics delivery |
| 07/02/2013 | CA2748249C Cyclic amine compounds |
| 07/02/2013 | CA2742946C Antioxidant |
| 07/02/2013 | CA2657469C Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 07/02/2013 | CA2576571C Preparation of antigen-presenting human .gamma..delta. t cells and use in immunotherapy |
| 07/02/2013 | CA2576419C Enzyme inhibitor in leukemia |
| 07/02/2013 | CA2575821C Dihydropteridinone infusion solution having a long shelf life |
| 07/02/2013 | CA2505558C T cell receptor display |
| 07/02/2013 | CA2485597C Process for preparation of cyclic prodrugs of pmea and pmpa |
| 07/02/2013 | CA2445729C Use of metals to treat mucosal membranes |
| 06/27/2013 | WO2013096926A1 E-selectin antagonist compounds, compositions, and methods of use |
| 06/27/2013 | WO2013096828A1 Surrogate binding proteins |
| 06/27/2013 | WO2013096687A1 Administration of hypoxia activated prodrugs in combination with chk1 inhibitors for treating cancer |
| 06/27/2013 | WO2013096684A1 Hypoxia activated prodrugs and mtor inhibitors for treating cancer |
| 06/27/2013 | WO2013096512A1 Pharmaceutical compositions and methods for treating gastrointestinal infections and disorders |
| 06/27/2013 | WO2013096335A1 Administration of an antagonist of alpha 5 beta 1 for anti-antiogenesis and cancer treatment |
| 06/27/2013 | WO2013096297A1 Methods to reduce polyposis and colorectal cancer |
| 06/27/2013 | WO2013096194A1 Novel heterocyclic carboxamides as modulators of kinase activity |
| 06/27/2013 | WO2013096060A1 Compounds for inhibiting the interaction of bcl2 with binding partners |
| 06/27/2013 | WO2013096059A1 Compounds for inhibiting the interaction of bcl2 with binding partners |
| 06/27/2013 | WO2013096055A1 Compounds for inhibiting the interaction of bcl2 with binding partners |
| 06/27/2013 | WO2013096051A1 Compounds for inhibiting the interaction of bcl2 with binding partners |
| 06/27/2013 | WO2013096049A1 Compounds for inhibiting the interaction of bcl2 with binding partners |
| 06/27/2013 | WO2013095905A1 Thyroid stimulating hormone compositions |
| 06/27/2013 | WO2013095738A2 Monoclonal antibodies with altered affinities for human fcyri, fcyrllla, and c1q proteins |
| 06/27/2013 | WO2013095736A2 Gold-in-silicon nanoassembly for thermal therapy and methods of use |
| 06/27/2013 | WO2013095684A1 Guanine analogs as telomerase substrates and telomere length affectors |
| 06/27/2013 | WO2013095286A2 Synergistic combination for tumor inhibition |
| 06/27/2013 | WO2013095132A1 Mirna for treating head and neck cancer |
| 06/27/2013 | WO2013094988A1 Method for producing natural killer cells, natural killer cells produced thereby, and composition for treating cancers and infectious diseases containing the same |
| 06/27/2013 | WO2013094722A1 Cancer cell-inhibiting ceramics and method for producing cancer cell-inhibiting ceramics, method for treating bone neoplasm, and use of β tricalcium phosphate porous granules having grain size of 1 to 10 μm |
| 06/27/2013 | WO2013094697A1 Anti-tumor peptide and use therefor |
| 06/27/2013 | WO2013094581A1 Novel camptothecin derivative |
| 06/27/2013 | WO2013093885A1 Inhibitors of notch signalling pathway and use thereof in treatment of cancers |
| 06/27/2013 | WO2013093850A1 Quinoline derivatives |
| 06/27/2013 | WO2013093849A1 Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives |
| 06/27/2013 | WO2013093707A1 Human growth hormone receptor antagonist antibodies and methods of use thereof |
| 06/27/2013 | WO2013093508A2 Wnt pathway inhibitors |
| 06/27/2013 | WO2013093379A1 Novel pharmaceutical compositions comprising an antibody which binds the human anti-mullerian hormone receptor type ii |
| 06/27/2013 | WO2013093248A1 Novel combinations containing n-hydroxy-4-(2-[3-(n, n-dimethylaminomethyl) benzofuran-2-ylcarbonylamino]ethoxy)benzamide in nasopharyngeal carcinoma |
| 06/27/2013 | WO2013093095A1 Bisarylsulfonamides useful in the treatment of inflammation and cancer |
| 06/27/2013 | WO2013092998A1 Enzymatic conjugation of antibodies |
| 06/27/2013 | WO2013092940A1 2, 4-diamine-pyrimidine derivative as serine/threonine kinase inhibitors |
| 06/27/2013 | WO2013092875A1 Vaccines against hpv |
| 06/27/2013 | WO2013092854A1 Pyrimidine-2,4-diamine derivatives as kinase inhibitors |
| 06/27/2013 | WO2013092753A1 Indole derivatives inhibitors of enzyme lactate dehydrogenase (ldh) |
| 06/27/2013 | WO2013092739A1 [1,2,4]triazolopyridines and their use as phospodiesterase inhibitors |
| 06/27/2013 | WO2013092574A1 Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals |
| 06/27/2013 | WO2013092556A1 Metal-chelating compounds having at least one polyamino chain |
| 06/27/2013 | WO2013092512A1 Substituted benzylpyrazoles |